Global Cholera Vaccine (Oral Route) Industry Insights: Market Size, Growth Analysis and Forecast
Report ID : 1303238 | Published : May 2025 | Study Period : 2023-2033 | Format : PDF + Excel
The market size of the Cholera Vaccine (Oral Route) Industry is categorized based on Product Type (Dukoral, Shanchol, Vaxchora, Others) and End-User (Hospitals, Clinics, Pharmacies, Non-Governmental Organizations (NGOs), Government Institutions) and Distribution Channel (Direct Sales, Retail Sales, Online Sales) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).
The Cholera Vaccine (Oral Route) Industry was worth $1.2 billion in 2023 and is forecasted to reach $2.5 billion by 2033, growing at a CAGR of 7.5% over the period 2024-2033. This report covers various segments and analyzes the key trends and factors influencing the market significantly.
The market for cholera vaccines, with an emphasis on oral vaccines, has attracted a lot of attention lately because cholera outbreaks are still a threat in many parts of the world. A serious public health concern, cholera is a highly contagious and potentially fatal diarrheal illness that is brought on by consuming tainted food or water. This is particularly true in poorer nations with poor water and sanitation systems. An important weapon in the worldwide battle against cholera is the oral route of vaccination, which provides a convenient and efficient method of immunization.
The market for cholera vaccines is expected to expand as the need for efficient preventive measures increases. The market dynamics are driven by elements including growing public knowledge of cholera prevention, government programs to increase vaccination coverage, and the continuous requirement for emergency responses to outbreaks. Furthermore, improvements in vaccine formulation and delivery techniques are bolstering oral cholera vaccines' overall effectiveness and acceptability, hence reinforcing their place in public health plans.
The market environment is changing, and a number of players, such as pharmaceutical firms, medical facilities, and governmental bodies, are essential to the accessibility and distribution of cholera vaccines. Analyzing the trends, obstacles, and opportunities that influence this crucial area of global health is essential as we dig deeper into the intricacies of the cholera vaccine (oral route) market.
| ATTRIBUTES | DETAILS |
| STUDY PERIOD | 2023-2033 |
| BASE YEAR | 2023 |
| FORECAST PERIOD | 2024-2033 |
| HISTORICAL PERIOD | 2023-2024 |
| UNIT | VALUE (USD BILLION) |
| KEY COMPANIES PROFILED | Valneva SE, Sanofi Pasteur, Janssen Pharmaceuticals, GlaxoSmithKline plc, Merck & Co. Inc., Pfizer Inc., Bharat Biotech, Serum Institute of India, Haffkine Bio-Pharmaceutical Corporation, Biological E. Limited, Zydus Cadila |
| SEGMENTS COVERED |
By Product Type - Dukoral, Shanchol, Vaxchora, Others
By End-User - Hospitals, Clinics, Pharmacies, Non-Governmental Organizations (NGOs), Government Institutions
By Distribution Channel - Direct Sales, Retail Sales, Online Sales
By Geography - North America, Europe, APAC, Middle East Asia & Rest of World. |
Cholera Vaccine (Oral Route) Industry Dynamics
The Cholera Vaccine (Oral Route) Industry is undergoing significant changes due to various dynamic factors. This section delves into the key drivers, restraints, opportunities, and challenges that are shaping the market landscape.
Market Drivers
- Technological Advancements
- Increasing Consumer Demand
- Regulatory Support
- Globalization
Market Restraints
- High Operational Costs
- Regulatory Challenges
- Market Saturation
Market Opportunities
- Emerging Markets
- Product Innovation
- Strategic Partnerships
Market Challenges
- Technological Disruptions
- Supply Chain Issues
- Changing Consumer Preferences
Cholera Vaccine (Oral Route) Industry Segmentations
Market Breakup by Product Type
- Overview
- Dukoral
- Shanchol
- Vaxchora
- Others
Market Breakup by End-User
- Overview
- Hospitals
- Clinics
- Pharmacies
- Non-Governmental Organizations (NGOs)
- Government Institutions
Market Breakup by Distribution Channel
- Overview
- Direct Sales
- Retail Sales
- Online Sales
Market Breakup by Region
North America
- United States of America
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Others
Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
Latin America
- Brazil
- Argentina
- Mexico
- Others
Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Key Players in the Cholera Vaccine (Oral Route) Industry
This report provides an in-depth analysis of both established and rising industry participants. It provides broad lists of important companies organized by the types of products they offer and other market-related factors. In addition to characterizing these companies, the report contains the year each player entered the market, which is useful for research analysis by the study's analysts.
- Valneva SE
- Sanofi Pasteur
- Janssen Pharmaceuticals
- GlaxoSmithKline plc
- Merck & Co. Inc.
- Pfizer Inc.
- Bharat Biotech
- Serum Institute of India
- Haffkine Bio-Pharmaceutical Corporation
- Biological E. Limited
- Zydus Cadila
Customization Options
Verified Industry Insights offers one of the following report customization options to our respectable clients :
Company Profiling
● Detailed profiling of additional market players (up to three players)
● SWOT analysis of key players (up to three players)
Competitive Benchmarking
● Benchmarking of key players on the following parameters : Product portfolio, geographical reach, regional presence, and strategic alliances.
Custom Research
Verified Industry Insights offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected] or call us at +1 743 222 5439
© 2024 Verified Industry Insights. All Rights Reserved